JP2008509987A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509987A5
JP2008509987A5 JP2007526616A JP2007526616A JP2008509987A5 JP 2008509987 A5 JP2008509987 A5 JP 2008509987A5 JP 2007526616 A JP2007526616 A JP 2007526616A JP 2007526616 A JP2007526616 A JP 2007526616A JP 2008509987 A5 JP2008509987 A5 JP 2008509987A5
Authority
JP
Japan
Prior art keywords
triazolo
alkyl
group
compound
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007526616A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509987A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2005/002868 external-priority patent/WO2006018735A2/en
Publication of JP2008509987A publication Critical patent/JP2008509987A/ja
Publication of JP2008509987A5 publication Critical patent/JP2008509987A5/ja
Withdrawn legal-status Critical Current

Links

JP2007526616A 2004-08-18 2005-08-08 トリアゾロピリジン化合物 Withdrawn JP2008509987A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60234404P 2004-08-18 2004-08-18
PCT/IB2005/002868 WO2006018735A2 (en) 2004-08-18 2005-08-08 Triazolopyridine compounds

Publications (2)

Publication Number Publication Date
JP2008509987A JP2008509987A (ja) 2008-04-03
JP2008509987A5 true JP2008509987A5 (https=) 2008-09-11

Family

ID=35735197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526616A Withdrawn JP2008509987A (ja) 2004-08-18 2005-08-08 トリアゾロピリジン化合物

Country Status (7)

Country Link
US (1) US20090209577A1 (https=)
EP (1) EP1786811A2 (https=)
JP (1) JP2008509987A (https=)
BR (1) BRPI0514327A (https=)
CA (1) CA2577478A1 (https=)
MX (1) MX2007002050A (https=)
WO (1) WO2006018735A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0514391A (pt) * 2004-08-18 2008-06-10 Pharmacia & Upjohn Co Llc compostos de triazolopiridina para o tratamento de inflamação
US7579360B2 (en) 2005-06-09 2009-08-25 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
US7572807B2 (en) 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
JP5336375B2 (ja) * 2006-08-30 2013-11-06 セルゾーム リミテッド キナーゼ阻害剤としてのトリアゾール誘導体
EP1894931A1 (en) * 2006-08-30 2008-03-05 Cellzome Ag Triazole derivatives as kinase inhibitors
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US8119658B2 (en) 2007-10-01 2012-02-21 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
MX2010005700A (es) 2007-11-27 2010-06-11 Cellzome Ltd Amino triazoles como inhibidores pi3k.
JO3041B1 (ar) 2008-07-25 2016-09-05 Galapagos Nv مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
WO2010010184A1 (en) * 2008-07-25 2010-01-28 Galapagos Nv [1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors
TWI453207B (zh) 2008-09-08 2014-09-21 Signal Pharm Llc 胺基三唑并吡啶,其組合物及使用其之治療方法
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
JO3030B1 (ar) 2009-06-26 2016-09-05 Galapagos Nv مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات
ES2443578T3 (es) 2009-12-29 2014-02-19 Eli Lilly And Company Compuestos de tetrahidrotriazolopiridina como potenciadores de receptores selectivos de mGlu5 útiles para el tratamiento de la esquizofrenia
EP3795573B1 (en) 2009-12-31 2022-07-06 Hutchison Medipharma Limited Certain triazolopyrazines, compositions thereof and methods of use therefor
GB201321742D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201402070D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Pharmaceutical compositions for the treatment of inflammatory disorders
GB201402071D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
AU2015328307B2 (en) * 2014-10-06 2019-11-21 Apm Therapeutics 1, Inc. Triazolopyridine compounds and methods for the treatment of cystic fibrosis
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
WO2017151409A1 (en) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Chemotherapeutic methods
GB201808575D0 (en) 2018-05-24 2018-07-11 Galapagos Nv Methods for the treatment of psoriatic arthrits
CA3165339A1 (en) * 2019-12-19 2021-06-24 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Cd206 modulators their use and methods for preparation
JP2025530213A (ja) 2022-09-09 2025-09-11 ミリックス ファーマ リミテッド Nmt阻害剤を含む抗体薬物コンジュゲート及びその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050525A (en) * 1960-12-14 1962-08-21 John B Bicking Certain derivatives of s-triazolo [4, 3-a]-pyridine
WO2001083481A1 (en) * 2000-04-27 2001-11-08 Yamanouchi Pharmaceutical Co., Ltd. Imidazopyridine derivatives
EE200300437A (et) * 2001-03-09 2004-02-16 Pfizer Products Inc. Triasolopüridiinid kui põletikuvastased ained
US6921762B2 (en) * 2001-11-16 2005-07-26 Amgen Inc. Substituted indolizine-like compounds and methods of use
AU2003249477A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Heterobicylcic metalloproteinase inhibitors
CA2515190A1 (en) * 2003-02-14 2004-08-26 Pfizer Products Inc. Triazolo-pyridines as anti-inflammatory compounds

Similar Documents

Publication Publication Date Title
JP2008509987A5 (https=)
JP2016164184A5 (https=)
JP2014516074A5 (https=)
JP2013521288A5 (https=)
JP2013521285A5 (https=)
JP2013523710A5 (https=)
JP2018534326A5 (https=)
RU2017125025A (ru) Конденсированные кольцевые гетероарильные соединения и их применение в качестве ингибиторов trk
JP2021501220A5 (https=)
HRP20151310T2 (hr) Spojevi piridazinona i njihova uporaba kao inhibitori daao
CA2596013A1 (en) Benzoimidazole derivatives and pharmaceutical composition comprising the same
HRP20240161T1 (hr) Inhibitor atr i njegova primjena
JP2009523812A5 (https=)
JP2011506480A5 (https=)
HRP20192274T1 (hr) Novi derivati oktahidro-pirolo[3,4−c]-pirola i njihovi analozi kao inhibitori autotaksina
JP2018519323A5 (https=)
RU2019111882A (ru) Антагонисты trpv4
RU2011147181A (ru) Азетидинилдиамиды в качестве ингибиторов моноациглицерин-липазы
JP2019532052A5 (https=)
JP2013505969A5 (https=)
RU2003111754A (ru) Производные пиридина с активностью ингибирования /кв-киназы (/кк-бета)
JP2014509316A5 (https=)
JP2013501720A5 (https=)
JP2009543867A5 (https=)
RU2010125220A (ru) Ненуклеозидные ингибиторы обратной транскриптазы